Berikutnya

Putar otomatis

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 Tampilan • 06/15/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis